45 related articles for article (PubMed ID: 38551744)
1. Role of ghrelin hormone in the development of alcohol-associated liver disease.
Mahalingam S; Bellamkonda R; Kharbanda KK; Arumugam MK; Kumar V; Casey CA; Leggio L; Rasineni K
Biomed Pharmacother; 2024 May; 174():116595. PubMed ID: 38640709
[TBL] [Abstract][Full Text] [Related]
2. β-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice.
Liu S; Yeh TH; Singh VP; Shiva S; Krauland L; Li H; Zhang P; Kharbanda K; Ritov V; Monga SP; Scott DK; Eagon PK; Behari J
Hepatology; 2012 Mar; 55(3):931-40. PubMed ID: 22031168
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
Satishchandran A; Ambade A; Rao S; Hsueh YC; Iracheta-Vellve A; Tornai D; Lowe P; Gyongyosi B; Li J; Catalano D; Zhong L; Kodys K; Xie J; Bala S; Gao G; Szabo G
Gastroenterology; 2018 Jan; 154(1):238-252.e7. PubMed ID: 28987423
[TBL] [Abstract][Full Text] [Related]
4. PKCε contributes to chronic ethanol-induced steatosis in mice but not inflammation and necrosis.
Kaiser JP; Guo L; Beier JI; Zhang J; Bhatnagar A; Arteel GE
Alcohol Clin Exp Res; 2014 Mar; 38(3):801-9. PubMed ID: 24483773
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-inducible gene 6 protein and its derived peptide ameliorate liver fibrosis by repressing CD44 activation in mice with alcohol-related liver disease.
Han J; Lee C; Jeong H; Jeon S; Lee M; Lee H; Choi YH; Jung Y
J Biomed Sci; 2024 May; 31(1):54. PubMed ID: 38790021
[TBL] [Abstract][Full Text] [Related]
6. Tgr5-/- mice are protected from ethanol-induced metabolic alterations through enhanced leptin and Fgf21 signaling.
Pokhrel S; Dilts M; Stahl Z; Boehme S; Frame G; Chiang JYL; Ferrell JM
Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37185802
[TBL] [Abstract][Full Text] [Related]
7. The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis.
Bala S; Csak T; Saha B; Zatsiorsky J; Kodys K; Catalano D; Satishchandran A; Szabo G
J Hepatol; 2016 Jun; 64(6):1378-87. PubMed ID: 26867493
[TBL] [Abstract][Full Text] [Related]
8. Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis.
Chao X; Wang S; Ma X; Zhang C; Qian H; Williams SN; Sun Z; Peng Z; Liu W; Li F; Sheshadri N; Zong WX; Ni HM; Ding WX
Hepatology; 2023 Aug; 78(2):503-517. PubMed ID: 36999531
[TBL] [Abstract][Full Text] [Related]
9. MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagy.
Yu X; Feng M; Guo J; Wang H; Yu J; Zhang A; Wu J; Han Y; Sun Z; Liao Y; Zhao Q
Cell Death Differ; 2024 May; ():. PubMed ID: 38783090
[TBL] [Abstract][Full Text] [Related]
10. PSTPIP2 protects against alcoholic liver injury and invokes STAT3-mediated suppression of apoptosis.
Yin NN; Chen X; Sun YY; Yang L; Zhang YF; Niu XN; Song H; Huang C; Li J
Biochem Pharmacol; 2024 May; 225():116334. PubMed ID: 38824967
[TBL] [Abstract][Full Text] [Related]
11. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
[TBL] [Abstract][Full Text] [Related]
12. The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers.
Chen H; McKeen T; Chao X; Chen A; Deng F; Jaeschke H; Ding WX; Ni HM
Int J Biol Sci; 2022; 18(3):1096-1106. PubMed ID: 35173541
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
14. The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.
Levin I; Petrasek J; Szabo G
Alcohol Clin Exp Res; 2012 Aug; 36(8):1397-406. PubMed ID: 22376231
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
Im KH; Saeed WK; Kim EB; Lee AH; Kim JE; Lee SM; Hanning X; Kim HS; Jun DW; Yoon EL
Dig Dis Sci; 2024 May; 69(5):1701-1713. PubMed ID: 38551744
[TBL] [Abstract][Full Text] [Related]
16. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase.
Saeed WK; Jun DW; Jang K; Oh JH; Chae YJ; Lee JS; Koh DH; Kang HT
J Gastroenterol Hepatol; 2019 Dec; 34(12):2206-2218. PubMed ID: 31132314
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
